Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001367644-22-000070
Filing Date
2022-04-29
Accepted
2022-04-28 17:44:29
Documents
118
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ebs-20220331.htm   iXBRL 10-Q 1735214
2 EX-10.1 biothraxcontractmod27edg.htm EX-10.1 4692
3 EX-10.3 fehconsulting.htm EX-10.3 58475
4 EX-31.1 a311-kramercert111.htm EX-31.1 8594
5 EX-31.2 a312-lindhalcert111.htm EX-31.2 8660
6 EX-32.1 a321-kramercert111.htm EX-32.1 3632
7 EX-32.2 a322-lindhalcert111.htm EX-32.2 3492
13 GRAPHIC biothraxcontractmod27edg001.jpg GRAPHIC 223760
14 GRAPHIC ebs-20220331_g1.jpg GRAPHIC 75656
15 GRAPHIC ebs-20220331_g2.jpg GRAPHIC 47961
16 GRAPHIC ebs-20220331_g3.jpg GRAPHIC 27878
17 GRAPHIC ebs-20220331_g4.jpg GRAPHIC 28279
18 GRAPHIC ebs-20220331_g5.jpg GRAPHIC 29233
19 GRAPHIC ebs-20220331_g6.jpg GRAPHIC 26736
20 GRAPHIC ebs-20220331_g7.jpg GRAPHIC 24031
21 GRAPHIC ebs-20220331_g8.jpg GRAPHIC 30199
22 GRAPHIC ebs-20220331_g9.jpg GRAPHIC 24528
23 GRAPHIC fehconsulting001.jpg GRAPHIC 247250
24 GRAPHIC fehconsulting002.jpg GRAPHIC 311862
25 GRAPHIC fehconsulting003.jpg GRAPHIC 335169
26 GRAPHIC fehconsulting004.jpg GRAPHIC 306193
27 GRAPHIC fehconsulting005.jpg GRAPHIC 315388
28 GRAPHIC fehconsulting006.jpg GRAPHIC 302390
29 GRAPHIC fehconsulting007.jpg GRAPHIC 321634
30 GRAPHIC fehconsulting008.jpg GRAPHIC 262818
31 GRAPHIC fehconsulting009.jpg GRAPHIC 281514
32 GRAPHIC fehconsulting010.jpg GRAPHIC 119540
33 GRAPHIC fehconsulting011.jpg GRAPHIC 51631
34 GRAPHIC fehconsulting012.jpg GRAPHIC 189965
35 GRAPHIC fehconsulting013.jpg GRAPHIC 134979
36 GRAPHIC fehconsulting014.jpg GRAPHIC 50518
37 GRAPHIC fehconsulting015.jpg GRAPHIC 280472
38 GRAPHIC fehconsulting016.jpg GRAPHIC 117502
39 GRAPHIC fehconsulting017.jpg GRAPHIC 237009
40 GRAPHIC fehconsulting018.jpg GRAPHIC 263888
41 GRAPHIC fehconsulting019.jpg GRAPHIC 72704
  Complete submission text file 0001367644-22-000070.txt   14562101

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ebs-20220331.xsd EX-101.SCH 44466
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ebs-20220331_cal.xml EX-101.CAL 71645
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ebs-20220331_def.xml EX-101.DEF 259614
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ebs-20220331_lab.xml EX-101.LAB 587434
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ebs-20220331_pre.xml EX-101.PRE 427742
112 EXTRACTED XBRL INSTANCE DOCUMENT ebs-20220331_htm.xml XML 1293659
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

EIN.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33137 | Film No.: 22868438
SIC: 2834 Pharmaceutical Preparations